Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 15 May 2023

A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours

in Pharmacology of Anti-Cancer Drugs

Lilian L. Nohara
Samantha L. S. Ellis
Carola Dreier
Sarah Dada
Iryna Saranchova
Kyong Bok Choi
Lonna Munro
Cheryl G. Pfeifer
Eliana Al Haddad
Krysta M. Coyle

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1119607

3,441 views
8 citations

Review

Published on 12 May 2023

Research progress of interleukin-15 in cancer immunotherapy

in Pharmacology of Anti-Cancer Drugs

Menghan Cai
Xuan Huang
Xiting Huang
Dianwen Ju
Yi Zhun Zhu
Li Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1184703

19,532 views
52 citations

Review

Published on 12 May 2023

The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy

in Pharmacology of Anti-Cancer Drugs

Jiaao Sun
Liyan Yu
Xueling Qu
Tao Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1184794

7,123 views
26 citations

Original Research

Published on 11 May 2023

Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Ke Shi
Yufei Bi
Xuanwei Zeng
Xianbo Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1163304

3,297 views
7 citations

Original Research

Published on 11 May 2023

Amino acid modified OCMC-g-Suc-β-CD nanohydrogels carrying lapatinib and ginsenoside Rg1 exhibit high anticancer activity in a zebrafish model

in Pharmacology of Anti-Cancer Drugs

Li Cui
Xiaolan Liu
Rongjun Yan
Qixu Chen
Lizhen Wang
Shah Nawaz
Dawei Qin
Daijie Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1149191

2,446 views
5 citations

Case Report

Published on 11 May 2023

Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report

in Pharmacology of Anti-Cancer Drugs

Fangfang Gao
Jingtai Li
Haoran Liao
Pingming Fan
Minjian Wang
Yu Liu
Linwei Ding
Guankui Du

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1115422

1,594 views
1 citation

Original Research

Published on 10 May 2023

Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites

in Pharmacology of Anti-Cancer Drugs

Yawen Zou
Ying Sun
Xinhua Chen
Liangjie Hong
Gang Dong
Xiwen Bai
Haiyu Wang
Benchen Rao
Zhigang Ren
Zujiang Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1163628

3,304 views

Original Research

Published on 10 May 2023

Detection of herpes simplex virus in oral tongue squamous cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Tiina Koivikko
Priscila Campioni Rodrigues
Mari Vehviläinen
Petra Hyvönen
Elias Sundquist
Riikka K. Arffman
Ahmed Al-Samadi
Hanna Välimaa
Tuula Salo
Maija Risteli

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1182152

5,190 views
10 citations

Review

Published on 10 May 2023

CircRNA-miRNA-VEGFA: an important pathway to regulate cancer pathogenesis

in Pharmacology of Anti-Cancer Drugs

Lei Zhang
Yuan Zhang
Xin Li
Huijuan Gao
Xiatian Chen
Peifeng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1049742

4,920 views
24 citations

Original Research

Published on 09 May 2023

Co-delivery of doxorubicin and hydroxychloroquine via chitosan/alginate nanoparticles for blocking autophagy and enhancing chemotherapy in breast cancer therapy

in Pharmacology of Anti-Cancer Drugs

Hui Zhang
Qingwen Xue
Zihan Zhou
Ningning He
Shangyong Li
Cheng Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1176232

4,743 views
17 citations

Editorial

Published on 09 May 2023

Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies

in Pharmacology of Anti-Cancer Drugs

Fangfang Tao
Zhiqian Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1208518

2,230 views
7 citations

Original Research

Published on 09 May 2023

Identification of afatinib-associated ADH1B and potential small-molecule drugs targeting ADH1B for hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Liang Yu
Xudong Zhao
Peng Huang
Risheng He
Yunfu Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1166454

4,150 views
8 citations

Original Research

Published on 09 May 2023

RETRACTED: Mechanism of action of Asparagus officinalis extract against multiple myeloma using bioinformatics tools, in silico and in vitro study

in Pharmacology of Anti-Cancer Drugs

Yanju Li
Xu Yang
Feiqing Wang
Jianing Zhao
Chike Zhang
Dan Wu
Bo Yang
Rui Gao
Peng Zhao
Yun Zan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1076815

7,289 views
7 citations

Review

Published on 09 May 2023

Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel

in Pharmacology of Anti-Cancer Drugs

Mário Sousa-Pimenta
Letícia M. Estevinho
Agnieszka Szopa
Mahnoor Basit
Khushbukhat Khan
Muhammad Armaghan
Manshuk Ibrayeva
Eda Sönmez Gürer
Daniela Calina
Christophe Hano

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1157306

15,520 views
73 citations

Original Research

Published on 09 May 2023

In-situ formed thermosensitive hydrogel amplifies statin-mediated immune checkpoint blockade for coordinated tumor chemo-immunotherapy

in Pharmacology of Anti-Cancer Drugs

Zefan Liu
Yajun Zhang
Jinyu Huang
Yan Wang
Xin Kang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1154392

2,346 views
4 citations

Original Research

Published on 05 May 2023

Basic and clinical study of efficacy and adverse effects of flumatinib in Ph+ ALL

in Pharmacology of Anti-Cancer Drugs

Jun Wang
Jiafei Wu
Yijing Wang
Boyue Zheng
Yu Wang
Chuanyan Jiang
Mengying Zou
Hui Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1178393

3,700 views
4 citations